Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis

Area of Science:

• Neuroimmunology
• Immunology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
• T cell-mediated immune responses play a critical role in MS pathogenesis.
• Chemokine receptors, such as CCR2, CXCR3, and CCR4, are crucial for T cell trafficking and function.

Purpose of the Study:

• To investigate the expression of CCR2, CXCR3, and CCR4 on T cells in the blood and cerebrospinal fluid (CSF) of MS patients.
• To compare T cell chemokine receptor expression in MS patients with healthy controls and patients with other inflammatory neurological diseases (INDs).
• To evaluate the potential role of T cell chemokine receptor expression and Th1/Th2 balance in MS pathology.

Main Methods:

• Three-color flow cytometry was used to quantify T cell populations (CD4+ and CD8+) expressing CCR2, CXCR3, and CCR4.
• Samples included blood and CSF from MS patients, blood from healthy controls, and CSF from IND patients.

Main Results:

• The CD4(+)CXCR3(+)/CD4(+)CCR4(+) ratio, indicating Th1/Th2 balance, was significantly higher in both CSF and blood of MS patients compared to IND patients and healthy controls.
• The percentage of CCR2-positive T cells was significantly elevated in the CSF of MS patients.
• These findings suggest a distinct T cell profile in the central nervous system of MS patients.

Conclusions:

• Increased CCR2 expression on T cells in the CSF and a Th1/Th2 imbalance in MS patients may reflect underlying pathological processes.
• Chemokine receptor expression patterns offer potential insights into MS pathogenesis and could be targets for future therapies.